MICHELLE WILLIAMS: Open Payments
NPI 1912151531 · COLUMBIA, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$28,963 in 281 payments from 32 companies in 2025. Trend: 2023 $44,742 · 2024 $34,837 · 2025 $28,963
Honoraria: $12,027Speaker / faculty: $10,104Food & beverage: $6,153Travel & lodging: $567Education: $111
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 41 | $13,339 |
| Otsuka America Pharmaceutical, Inc. | 11 | $6,148 |
| ABBVIE INC. | 27 | $5,058 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 23 | $467 |
| Lundbeck LLC | 25 | $422 |
| E.R. Squibb & Sons, L.L.C. | 15 | $395 |
| Teva Pharmaceuticals USA, Inc. | 14 | $390 |
| Neurocrine BioSciences, Inc. | 14 | $387 |
| Alkermes, Inc. | 24 | $366 |
| Janssen Pharmaceuticals, Inc | 8 | $295 |
Products named: Auvelity, REXULTI, VRAYLAR, CAPLYTA, INGREZZA, ARISTADA, COBENFY, FANAPT.
Industry payments across MD — which companies pay providers there.
